arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

Why Are Supplement Ingredient Names So Confusing?

Have you ever heard of 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol or 4-[2-(dimethylamino)ethyl]phenol? Probably not. How about higenamine or hordenine? That may be more likely, but did you know that 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol and higenamine are actually the same ingredient? The same is true for 4-[2-(dimethylamino)ethyl]phenol and hordenine.  Ingredient names can be confusing because manufacturers don’t always follow guidelines set by the…

Continue Reading ›

New Supplement Website Certification Program Helps Sellers Reduce Advertising and E-commerce Disruptions

We’re pleased to announce today LegitScript’s newest certification program — one to certify the websites of dietary supplement sellers as a way for them to demonstrate credibility and regulatory compliance. Now, all US supplement manufacturers, resellers, and affiliates can apply through LegitScript to certify that their websites have been reviewed for problematic products, ingredients, and…

Continue Reading ›

“Alzheimer’s” on Track to Win LegitScript’s Infamous Yellow Flag Award for 2019

“Alzheimer’s” and related disease terms are on track to be this year’s top impermissible supplement marketing claim, which would earn it the LegitScript Yellow Flag Award for 2019. With four months still left in the year, will “Alzheimer’s” beat last year’s top impermissible claim — “inflammation” — or 2017’s winner, “cancer”? Only time and shady…

Continue Reading ›

Seizures Related to Vaping Highlight Risk of E-cigarette Merchants

The FDA said this week that it is investigating 127 incidents of people suffering from seizures after vaping. The news highlights the elevated risk e-cigarette products pose for legal violations, and why payment service providers should know about the many types of products and parts related to vaping to better monitor their portfolios.  The FDA’s…

Continue Reading ›

CBD Confusion in Iowa Highlights the Difficulty in Navigating Local CBD Laws

The Iowa Attorney General’s Office recently reminded Iowans that cannabidiol (CBD) is still considered a controlled substance in the state despite the newly passed Iowa Hemp Act, which legalized the production of hemp containing less than 0.3% THC. The confusion has resulted in enforcement efforts to stop its sale, and it illustrates a larger legal…

Continue Reading ›

The Top Marketing Claims CBD Merchants and Manufacturers Should Avoid

One of the aspects of cannabidiol (CBD) sales that can attract regulatory scrutiny is the way in which merchants market their CBD products. In the past five years, the FDA has sent many warning letters to manufacturers and merchants of CBD products for claims that their products can prevent, cure, mitigate, or treat diseases. No…

Continue Reading ›

LegitScript Announces New CBD Certification Program

We’re happy to announce a new certification program for legally compliant CBD products and websites. Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript is the global leader in merchant and…

Continue Reading ›

What the Blackstone Labs Indictment Means for Payment Service Providers

Last month, six people associated with Blackstone Labs were charged in an indictment to market and sell illegal dietary supplements for use in bodybuilding and weight loss. The indictment is significant because of the size and reach of Blackstone Labs, and because of the way it is alleged to have deceptively labeled products for years.…

Continue Reading ›

Three Things Payment Service Providers Need to Know About CBD Sales

The 2018 Farm Bill, which was signed into law last month, includes provisions removing hemp and its extracts, including hemp-derived cannabidiol (CBD), from the DEA’s Controlled Substances schedules entirely. This is a monumental shift for industrial hemp and CBD in the US, and it promises big opportunities for CBD merchants and the payment facilitators that…

Continue Reading ›

How Will the FDA’s New Dietary Supplement Working Group Affect You?

Food and Drug Administration Commissioner Scott Gottlieb announced last month a new working group to improve oversight of the dietary supplement industry. The move could mean increased safety for consumers, but also increased scrutiny of dietary supplement merchants and the payment facilitators that onboard them. An Unwieldy Industry In a speech at the Food and…

Continue Reading ›